Nexstim
Update in progressNXTMH.HE (Helsinki)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Nexstim Plc is a medical technology company focused on non-invasive brain stimulation. It develops and markets navigated transcranial magnetic stimulation (nTMS) systems, including the NBS System 6 for presurgical mapping of speech and motor areas, and its use in major depression, chronic unilateral neuropathic pain, and post‑operative upper-limb motor rehab. It serves universities and teaching hospitals worldwide, with partnerships with Sinaptica Therapeutics for Alzheimer's/MCI neuromodulation and Brainlab for motor and speech mapping. Founded 2000, Helsinki.
Company score
- Sentiment
- 0.50
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.01
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.23
- Governance
- 0.06
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.09
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.29
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketHelsinki (HEL)
- LocationFinland
- Founded2000
- Employees44
- Websitewww.nexstim.com
Identifiers
- ISINFI4000506811